Indefinite Delivery Contract SPE2DR25D3003
- Not listed
- The federal contract IDV award SPE2DR25D7059 is a $999,999,999 Indefinite Delivery Contract issued by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp. This single-award contract runs through December 31, 2036 and serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including...
- The federal contract IDV award SPE2DR25D6041, issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, is a $999,999,999 Indefinite Delivery Contract (IDC) to provide a comprehensive range of pharmaceutical products and medical supplies in support of military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic...
- The federal contract IDV award is a $999,999,999 Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This includes specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test...
- The federal contract IDV award SPE2DR25D3009 is a $999,999,999 Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp as the prime contractor. The contract provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple...
- The federal contract IDV award SPE2DR25D1051, issued by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain, is an Indefinite Delivery Contract (IDC) valued at $9,999,999,999 with a period of performance through December 31, 2036. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract aims to establish a Pharmaceutical Prime Vendor Global Program Generation V to provide worldwide pharmaceutical...
- The federal contract IDV award SPE2DR25D1100 is an Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,999,999,999, covers the provision of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name...
- The federal contract IDV award SPE2DR25D1103 is an Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $9,999,999,999, is for the provision of pharmaceutical products and medical supplies to support the healthcare needs of the Department of Defense (DoD), the United States Coast Guard, and...
- The federal contract IDV award SPE2DR25D6029 is a single-award Indefinite Delivery Contract (IDC) between the Defense Logistics Agency (DLA) Troop Support Medical and Amerisourcebergen Drug Corp. The $999,999,999 contract, which runs through December 2036, covers the provision of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This includes specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and...
- The federal contract IDV award SPE2DR25D2008 is a single-award Indefinite Delivery Contract (IDC) valued at $999,999,999.00 issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and...
- The federal contract IDV award SPE2DR25D3010 is a single-award Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $999,999,999 IDC has an ultimate completion date of December 31, 2026 and serves as a prime vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...
The federal contract IDV award SPE2DR25D3003 is a $999,999,999 Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract provides worldwide pharmaceutical support, including brand-name, generic, and specialty medications, as well as medical supplies and equipment, to various Department of Defense (DoD) customers, the U.S. Coast Guard, and other government agencies. The IDC has a 30-month base period and three 30-month option periods, for a total potential period of performance through December 2026. The original solicitation, a pre-solicitation for the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), indicates that DLA Troop Support plans to make multiple primary supplier awards for separate geographic regions (North/EUCOM, West/PACOM, South/SOUTHCOM, and Fleet) as well as a single backup supplier award. The acquisition is unrestricted and fully competitive, with awards made on a lowest price technically acceptable (LPTA) basis considering distribution fees for brand/generic and specialty pharmaceuticals. The total estimated value for all regions, including options, is $30.3 billion.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $0 | 3/7/25 |
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Pharmaceutical Prime Vendor Global GEN V Presolicitation | SPE2DX-24-R-0001 | Defense Logistics Agency Troop Support Medical | Pre-Solicitation 1/5 | 2/1/24, 3:44 PM | |
Pharmaceutical Prime Vendor Global GEN V Solicitation | SPE2DX-24-R-0001_SOLICITATION | Defense Logistics Agency Troop Support Medical | Solicitation 2/5 | 3/13/24, 11:08 AM | |
PPVG GEN V Award | SPE2DX-25-D-1000 | Defense Logistics Agency Troop Support Medical | Award Notice 3/5 | 3/7/25, 10:09 AM | |
PPVG GEN V AWARD SPE2DX25D9000 | SPE2DX25D9000 | Defense Logistics Agency Troop Support Medical | Award Notice 4/5 | 3/7/25, 10:14 AM | |
PPVG GEN V AWARD SPE2DX25D8000 | SPE2DX25D8000 | Defense Logistics Agency Troop Support Medical | Award Notice 5/5 | 3/7/25, 10:18 AM |